PROM1 and breast neoplasm: The stem cell marker CD133 was positively associated with hRNase 1 expression (Fig. 7c) and EphA4 activation (Fig. 7d), supporting the pathological features of the hRNase 1–EphA4 axis in breast tumor initiation (representative cases are shown in Fig. 7e).